MetRx "andro" ads
This article was originally published in The Tan Sheet
Executive Summary
MetRx revising ads for its fitness supplements to delete products containing androstenedione after ESPN and Fox Sports pulled the original ads in response to public outcry. The new ads are slated to air in late October. The controversy over the use of androstenedione is due to questions regarding its steroid nature and unknown side effects. MetRx is conducting several studies at Eastern Michigan University to determine the testosterone-related effects of androstenedione. In the first of five studies, the company is dosing eight male college-age subjects on a rotating basis with either placebo, 100 mg androstenedione or 100 mg androstenediol, a similar substance, with a three-day washout period between treatments, then comparing blood levels of testosterone to baseline at various points up to 90 minutes post-dose. MetRx says androstenediol is three times more potent than androstenedione. Testosterone levels for all subjects have remained within normal physiological levels
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning